RS
RAVI SAKLANI
The Ohio State University, Hebrew University of Jerusalem, CSIR-Central Drug Research Institute, Delhi Institute of Pharmaceutical Sciences and Research
Employment
-
The Ohio State University Postdoc2024 - Present
-
Hebrew University of Jerusalem Post Doctoral Researcher2022 - 2023
-
CSIR-Central Drug Research Institute Project JRF2017 - 2017
-
CSIR-Central Drug Research Institute Project Fellow2016 - 2017
Education
-
CSIR-Central Drug Research Institute Doctorate Degree (PhD)2017 - 2022
-
Delhi Institute of Pharmaceutical Sciences and Research Master in Pharmacy2013 - 2015
-
Delhi Institute of Pharmaceutical Sciences and Research Bachelor in Pharmacy (B. Pharm)2010 - 2013
-
Delhi Institute of Pharmaceutical Sciences and Research Diploma in Pharmacy (D. Pharm)2007 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- Development of HPLC Method for Simultaneous Quantification of Doxorubicin and Baicalein Encapsulated in Unilamellar Liposomes Save
- Peptide and Protein Stereocomplexes Save
- Simultaneous estimation of paclitaxel and bortezomib via LC-MS/MS: pharmaceutical and pharmacokinetic applications Save
- Sustained insulin treatment restoring metabolic status, body weight, and cognition in an anorexia nervosa-like animal model in mice Save
- Synchronized Codelivery of Combination Chemotherapies Intratumorally Using a Lipidic Lyotropic Liquid Crystal System Save
- Technology Transfer of a Validated RP-HPLC Method for the Simultaneous Estimation of Andrographolide and Paclitaxel in Application to Pharmaceutical Nanoformulation Save
- Development and validation of simultaneous quantification method for gemcitabine and betulinic acid: augmenting industrial application Save
- Enhanced apoptosis and mitochondrial cell death by paclitaxel-loaded TPP-TPGS1000-functionalized nanoemulsion Save
- Ratiometric codelivery of Paclitaxel and Baicalein loaded nanoemulsion for enhancement of breast cancer treatment Save
- Effective uptake of folate-functionalized ethionamide-loaded hybrid system: targeting alveolar macrophages Save